arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

IRIDEX Corporation

IRIX Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$0.76
▲ +0.3% Today
as of Oct 22, 16:49 ET
Last 30 days +18.75% Sep 14 → Oct 22
$0.58 $0.68 $0.77 $0.86 $0.96 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.79
High
$0.79
Low
$0.75
Volume
$16,156
Avg Vol
$204,247
Mkt Cap
$11M
P/E (TTM)
—
Beta
—
52w High
$1.65
52w Low
$0.61
Div Yield
—
Shares Out
$17M

Recent Press Releases & News last 60 days · 4 items

Oct 12 · 11:00 PR GlobeNewswire
Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
Oct 5 · 11:00 PR GlobeNewswire
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
Aug 25 · 22:59 Motley Fool
IRIDEX (IRIX) Q2 2026 Earnings Call Transcript
▸ Show all 4 press releases & news Free account →

IRIX earnings at a glance

The options market is pricing a move of about ±361.9% after the report, a range of roughly -$1.99 to $3.51 from today's $0.76. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.6% on average; after the most recent report on May 19, 2026 it moved +2.9%. That means options currently expect more movement than IRIX has typically delivered. Implied volatility is currently 31%. The share price of $0.76 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.61
$1.65
14% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-0.7%
50% positive
Latest IV / EM
3064%
EM ±361.9% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.21$-0.16$-0.12$-0.07$-0.03 Actual $-0.13Actual $-0.17Actual $-0.11Actual $-0.21Actual $-0.16Actual $-0.12Actual $-0.10Actual $-0.06Actual $-0.09Actual $-0.03Actual $-0.07 AprJulSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jul
Revenue vs Net Income Revenue Net income
$-2M$2M$6M$10M$14M Sep 24Mar 25Jun 25Sep 25Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Sat Jul 4, 2026Jul 2026 $-0.07 — — — — financials
Tue May 19, 2026Mar/2026 $-0.03 — — +70.0% +2.9% earnings
Tue Nov 11, 2025Sep/2025 $-0.09 — — — — earnings
Tue Aug 12, 2025Jun/2025 $-0.06 — — — — earnings
Tue May 13, 2025Mar/2025 $-0.10 — — — -4.3% earnings
Sat Sep 28, 2024Sep 2024 $-0.12 — — — — financials
Sat Jun 29, 2024Jun 2024 $-0.16 — — — — financials
Sat Mar 30, 2024Mar 2024 $-0.21 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.11 — — — — financials
Sat Jul 1, 2023Jul 2023 $-0.17 — — — — financials
Sat Apr 1, 2023Apr 2023 $-0.13 — — — — financials

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$13M$12M—$12M$14M$12M—$12M
Cost of revenue$8M$7M—$8M$9M$7M—$7M
Gross profit$4M$5M—$4M$5M$5M—$4M
Operating income$-1M$-324,000—$-1M$-940,000$-205,000—$-2M
Net income$-1M$-524,000—$-2M$-994,000$-2M—$-2M
EPS (diluted)$-0.07$-0.03—$-0.09$-0.06$-0.10—$-0.12

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$5M$5M$6M$6M$7M$7M$2M$4M
Inventory$10M$9M$8M$7M$8M$10M$11M$11M
Total current assets$24M$25M$25M$24M$27M$29M$24M$24M
Total assets$27M$28M$29M$28M$32M$34M$29M$30M
Long-term debt———————$1M
Total liabilities$24M$24M$24M$24M$26M$27M$27M$28M
Total equity$4M$5M$5M$5M$6M$852,000$2M$3M

Implied volatility — last 90 days

1061%4286%7511%10736%13961% Jun 07 — IV 1755% · EM ±243.1%Jun 08 — IV 2119% · EM ±279.8%Jun 09 — IV 1960% · EM ±245.5%Jun 10 — IV 2023% · EM ±238.9%Jun 11 — IV 2182% · EM ±241.1%Jun 12 — IV 2444% · EM ±250.0%Jun 15 — IV 3277% · EM ±237.1%Jun 16 — IV 3628% · EM ±214.3%Jun 17 — IV 5423% · EM ±226.5%Jun 19 — IV 1061% · EM ±234.5%Jun 22 — IV 1094% · EM ±228.4%Jun 23 — IV 1098% · EM ±224.6%Jun 24 — IV 1133% · EM ±226.9%Jun 25 — IV 1146% · EM ±224.6%Jun 26 — IV 1165% · EM ±222.9%Jun 29 — IV 1318% · EM ±233.5%Jul 02 — IV 1450% · EM ±234.5%Jul 03 — IV 1501% · EM ±234.5%Jul 06 — IV 1708% · EM ±236.6%Jul 07 — IV 1859% · EM ±245.5%Jul 08 — IV 1924% · EM ±241.1%Jul 09 — IV 2079% · EM ±245.5%Jul 10 — IV 2263% · EM ±250.0%Jul 13 — IV 3469% · EM ±289.7%Jul 14 — IV 3618% · EM ±261.7%Jul 15 — IV 4590% · EM ±271.1%Jul 16 — IV 10071% · EM ±420.6%Jul 20 — IV 1441% · EM ±340.3%Jul 21 — IV 1480% · EM ±344.2%Jul 22 — IV 1438% · EM ±328.8%Jul 23 — IV 1857% · EM ±417.6%Jul 24 — IV 1981% · EM ±437.8%Jul 27 — IV 1751% · EM ±365.7%Jul 28 — IV 1775% · EM ±363.2%Jul 29 — IV 2283% · EM ±457.2%Jul 30 — IV 2021% · EM ±395.8%Jul 31 — IV 3122% · EM ±597.6%Aug 03 — IV 2600% · EM ±460.6%Aug 04 — IV 3540% · EM ±609.6%Aug 05 — IV 2837% · EM ±473.9%Aug 06 — IV 2725% · EM ±440.7%Aug 07 — IV 3082% · EM ±481.6%Aug 10 — IV 2721% · EM ±376.8%Aug 11 — IV 3276% · EM ±432.7%Aug 12 — IV 3082% · EM ±386.2%Aug 13 — IV 3339% · EM ±394.4%Aug 14 — IV 3436% · EM ±379.7%Aug 17 — IV 5782% · EM ±483.0%Aug 18 — IV 4831% · EM ±349.5%Aug 19 — IV 13408% · EM ±791.9%Aug 20 — IV 10799% · EM ±451.0%Aug 24 — IV 2218% · EM ±463.1%Aug 25 — IV 2355% · EM ±481.8%Aug 26 — IV 2506% · EM ±501.8%Aug 27 — IV 2544% · EM ±498.4%Aug 28 — IV 2626% · EM ±502.5%Aug 31 — IV 2769% · EM ±490.6%Sep 01 — IV 3435% · EM ±591.5%Sep 02 — IV 2947% · EM ±492.3%Sep 03 — IV 3132% · EM ±506.6%Sep 04 — IV 3265% · EM ±510.2%Sep 07 — IV 3661% · EM ±507.1%Sep 08 — IV 3995% · EM ±527.5%Sep 09 — IV 4284% · EM ±536.8%Sep 10 — IV 4452% · EM ±525.8%Sep 11 — IV 5005% · EM ±553.0%Sep 14 — IV 6828% · EM ±570.3%Sep 15 — IV 7978% · EM ±577.1%Sep 16 — IV 10460% · EM ±617.8%Sep 17 — IV 13962% · EM ±583.1%Sep 21 — IV 2532% · EM ±528.8%Sep 22 — IV 2423% · EM ±495.7%Sep 23 — IV 2756% · EM ±552.0%Sep 24 — IV 2696% · EM ±528.0%Sep 25 — IV 2884% · EM ±552.0%Sep 28 — IV 2958% · EM ±524.1%Sep 29 — IV 2927% · EM ±503.9%Sep 30 — IV 3231% · EM ±539.7%Oct 01 — IV 3326% · EM ±538.0%Oct 02 — IV 3190% · EM ±498.4%Oct 06 — IV 3563% · EM ±470.6%Oct 07 — IV 2827% · EM ±354.2%Oct 08 — IV 3064% · EM ±361.9%

Sector peers

NDRA
ENDRA Life Sciences Inc.
$9M $4.78+6.9%
NXL
Nexalin Technology, Inc.
$6M $2.03-5.1%
ITOC
iTonic Holdings Ltd
$5M $3.23-3.6%
VBIO
Valion Bio, Inc.
$3M $0.96-19.7%
NUWE
Nuwellis, Inc.
$3M $0.49-11.3%
QTI
QT Imaging Holdings, Inc.
$42M $2.35+1.1%

IRIX earnings FAQ

What is IRIX's expected move for earnings?

Options currently price a move of about ±361.9%, or $2.75 per share either way from $0.76.

How does IRIX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.6%, up 1 times and down 1 times.

What is IRIX's implied volatility?

IRIX's at-the-money implied volatility is about 31% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in